An ivermectin – atorvastatin combination impairs nuclear transport inhibiting dengue infection in vitro and in vivo-Reference-Cited by-同舟云学术

An ivermectin – atorvastatin combination impairs nuclear transport inhibiting dengue infection in vitro and in vivo

Published:2023-12 Issue:12 Volume:26 Page:108294
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Palacios-Rápalo Selvin Noé,Farfan-Morales Carlos Noe,Cordero-Rivera Carlos Daniel,De Jesús-González Luis Adrián,Reyes-Ruiz José Manuel,Meraz-Ríos Marco Antonio,Del Ángel Rosa María

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference70 articles.

1. OPS/OMS;Sanchez,2009

2. Dengue Treatment for Healthcare Providers | CDC,2019

3. Drug repurposing: progress, challenges and recommendations;Pushpakom;Nat. Rev. Drug Discov.,2019

4. Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2;Martinez-Gutierrez;PLoS One,2014

5. Ezetimibe inhibits dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann-Pick C1-like 1 receptor;Osuna-Ramos;Antivir. Res.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition;Molecules;2024-08-27

2. Protocol to evaluate the antiviral effect of FDA-approved drugs against dengue virus in Huh7 cells and AG129 mice;STAR Protocols;2024-06

3. Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients;Infectious Disease Reports;2024-05-16

4. A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin;Microorganisms;2024-02-13